You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study

Citation Tools

Article menu

Download PDFPDF

XML
Research Article
Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Forschner A, Battke F, Hadaschik D, et al
Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study
Journal for ImmunoTherapy of Cancer 2019;7:180. doi: 10.1186/s40425-019-0659-0